RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.

Diana Severynse-Stevens
Experts

Diana Severynse-Stevens

Senior Director, Drug Development, Global Health

Education

PhD, Microbiology, University of North Carolina at Chapel Hill
BS, Biology, State University of New York, Binghamton


Diana M. Severynse-Stevens, PhD, has more than 25 years of experience in the pharmaceutical industry, and more than 20 years of experience in product development, including work in drug discovery, preclinical and clinical drug development. She provides regulatory guidance and expertise to clients in preclinical and clinical development of pharmaceuticals.

Dr. Severynse-Stevens has focused her work on projects supporting translational research in several therapeutic areas including infectious, metabolic and cardiovascular diseases. She has helped to identify and manage contract research organizations, analyze data, and track activities and timing for these projects.

Previously, she worked at DARA Biosciences, Nobex Corporation, Wyeth-Ayerst Pharmaceuticals, and Procter & Gamble Pharmaceuticals. She has an extensive background in program management, clinical and regulatory writing, and pharmacology.

Get in Touch

To speak to this expert or inquire about RTI services, you can reach us at +1 919 541 6000 or use the contact form below. For media inquiries, please reach out to our Media Relations team at news@rti.org.

Blue background circle graphics